Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Neural bases for addictive properties of benzodiazepines

Nature volume 463, pages 769–774 (2010)Cite this article

Subjects

Abstract

Benzodiazepines are widely used in clinics and for recreational purposes, but will lead to addiction in vulnerable individuals. Addictive drugs increase the levels of dopamine and also trigger long-lasting synaptic adaptations in the mesolimbic reward system that ultimately may induce the pathological behaviour. The neural basis for the addictive nature of benzodiazepines, however, remains elusive. Here we show that benzodiazepines increase firing of dopamine neurons of the ventral tegmental area through the positive modulation of GABAA (γ-aminobutyric acid type A) receptors in nearby interneurons. Such disinhibition, which relies on α1-containing GABAA receptors expressed in these cells, triggers drug-evoked synaptic plasticity in excitatory afferents onto dopamine neurons and underlies drug reinforcement. Taken together, our data provide evidence that benzodiazepines share defining pharmacological features of addictive drugs through cell-type-specific expression of α1-containing GABAA receptors in the ventral tegmental area. The data also indicate that subunit-selective benzodiazepines sparing α1 may be devoid of addiction liability.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: BDZ-evoked synaptic plasticity is abolished in α1(H101R) mutant mice.
Figure 2: Synaptic plasticity evoked by α1-subunit-selective compounds.
Figure 3: α1 is selectively expressed in GABA neurons of the VTA.
Figure 4: The total current generated by sIPSCs in DA neurons is decreased by MDZ.
Figure 5: Opposing effects of MDZ on in vivo firing rates of DA and GABA neurons.
Figure 6: Oral self-administration of MDZ.

Similar content being viewed by others

References

  1. Lüscher, C. & Ungless, M. A. The mechanistic classification of addictive drugs. PLoS Med. 3, e437 (2006)

    Article  Google Scholar 

  2. O’Brien, C. P. Benzodiazepine use, abuse, and dependence. J. Clin. Psychiatry 66 (suppl. 2). 28–33 (2005)

    Article  Google Scholar 

  3. Saal, D., Dong, Y., Bonci, A. & Malenka, R. C. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37, 577–582 (2003)

    Article  CAS  Google Scholar 

  4. Bellone, C. & Lüscher, C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nature Neurosci. 9, 636–641 (2006)

    Article  CAS  Google Scholar 

  5. Argilli, E., Sibley, D. R., Malenka, R. C., England, P. M. & Bonci, A. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J. Neurosci. 28, 9092–9100 (2008)

    Article  CAS  Google Scholar 

  6. Mameli, M., Balland, B., Lujan, R. & Luscher, C. Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area. Science 317, 530–533 (2007)

    Article  ADS  CAS  Google Scholar 

  7. Heikkinen, A. E., Moykkynen, T. P. & Korpi, E. R. Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists. Neuropsychopharmacol. 34, 290–298 (2009)

    Article  CAS  Google Scholar 

  8. Johnson, S. W. & North, R. A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J. Physiol. (Lond.) 450, 455–468 (1992)

    Article  CAS  Google Scholar 

  9. Sigel, E., Schaerer, M. T., Buhr, A. & Baur, R. The benzodiazepine binding pocket of recombinant α1β2γ2 γ-aminobutyric acidA receptors: relative orientation of ligands and amino acid side chains. Mol. Pharmacol. 54, 1097–1105 (1998)

    Article  CAS  Google Scholar 

  10. Fritschy, J. M. & Mohler, H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154–194 (1995)

    Article  CAS  Google Scholar 

  11. Okada, H., Matsushita, N., Kobayashi, K. & Kobayashi, K. Identification of GABAA receptor subunit variants in midbrain dopaminergic neurons. J. Neurochem. 89, 7–14 (2004)

    Article  CAS  Google Scholar 

  12. Arendt, R. M., Greenblatt, D. J., Liebisch, D. C., Luu, M. D. & Paul, S. M. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity. Psychopharmacology (Berl.) 93, 72–76 (1987)

    Article  CAS  Google Scholar 

  13. Rudolph, U. et al. Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes. Nature 401, 796–800 (1999)

    Article  ADS  CAS  Google Scholar 

  14. Möhler, H., Benke, D., Mertens, S. & Fritschy, J. M. GABAA-receptor subtypes differing in α-subunit composition display unique pharmacological properties. Adv. Biochem. Psychopharmacol. 47, 41–53 (1992)

    PubMed  Google Scholar 

  15. McKernan, R. M. et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor alpha1 subtype. Nature Neurosci. 3, 587–592 (2000)

    Article  CAS  Google Scholar 

  16. Cameron, D. L., Wessendorf, M. W. & Williams, J. T. A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience 77, 155–166 (1997)

    Article  CAS  Google Scholar 

  17. Margolis, E. B., Lock, H., Hjelmstad, G. O. & Fields, H. L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J. Physiol. (Lond.) 577, 907–924 (2006)

    Article  CAS  Google Scholar 

  18. Hsia, A. Y., Malenka, R. C. & Nicoll, R. A. Development of excitatory circuitry in the hippocampus. J. Neurophysiol. 79, 2013–2024 (1998)

    Article  CAS  Google Scholar 

  19. Poncer, J. C., Durr, R., Gähwiler, B. H. & Thompson, S. M. Modulation of synaptic GABAA receptor function by benzodiazepines in area CA3 of rat hippocampal slice cultures. Neuropharmacology 35, 1169–1179 (1996)

    Article  CAS  Google Scholar 

  20. Long, P. et al. Nerve terminal GABAA receptors activate Ca2+/calmodulin-dependent signaling to inhibit voltage-gated Ca2+ influx and glutamate release. J. Biol. Chem. 284, 8726–8737 (2009)

    Article  CAS  Google Scholar 

  21. Barberis, A., Mozrzymas, J. W., Ortinski, P. I. & Vicini, S. Desensitization and binding properties determine distinct α1β2γ2 and α3β2γ2 GABAA receptor-channel kinetic behavior. Eur. J. Neurosci. 25, 2726–2740 (2007)

    Article  Google Scholar 

  22. Yee, B. K. et al. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc. Natl Acad. Sci. USA 102, 17154–17159 (2005)

    Article  ADS  CAS  Google Scholar 

  23. Löw, K. et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131–134 (2000)

    Article  ADS  Google Scholar 

  24. Robinson, S., Smith, D. M., Mizumori, S. J. & Palmiter, R. D. Firing properties of dopamine neurons in freely moving dopamine-deficient mice: effects of dopamine receptor activation and anesthesia. Proc. Natl Acad. Sci. USA 101, 13329–13334 (2004)

    Article  ADS  CAS  Google Scholar 

  25. Hyland, B. I., Reynolds, J. N., Hay, J., Perk, C. G. & Miller, R. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114, 475–492 (2002)

    Article  CAS  Google Scholar 

  26. Pilotto, R., Singer, G. & Overstreet, D. Self-injection of diazepam in naive rats: effects of dose, schedule and blockade of different receptors. Psychopharmacology (Berl.) 84, 174–177 (1984)

    Article  CAS  Google Scholar 

  27. Fuchs, V., Burbes, E. & Coper, H. The influence of haloperidol and aminooxyacetic acid on etonitazene, alcohol, diazepam and barbital consumption. Drug Alcohol Depend. 14, 179–186 (1984)

    Article  CAS  Google Scholar 

  28. Berridge, K. C. & Pecina, S. Benzodiazepines, appetite, and taste palatability. Neurosci. Biobehav. Rev. 19, 121–131 (1995)

    Article  CAS  Google Scholar 

  29. Yerbury, R. E. & Cooper, S. J. Novel benzodiazepine receptor ligands: palatable food intake following zolpidem, CGS 17867A, or Ro23–0364, in the rat. Pharmacol. Biochem. Behav. 33, 303–307 (1989)

    Article  CAS  Google Scholar 

  30. Morris, H. V., Nilsson, S., Dixon, C. I., Stephens, D. N. & Clifton, P. G. α1- and α2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia. Appetite 52, 675–683 (2009)

    Article  CAS  Google Scholar 

  31. Kalivas, P. W., Duffy, P. & Eberhardt, H. Modulation of A10 dopamine neurons by γ-aminobutyric acid agonists. J. Pharmacol. Exp. Ther. 253, 858–866 (1990)

    CAS  PubMed  Google Scholar 

  32. Xi, Z. X. & Stein, E. A. Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study. Brain Res. 798, 156–165 (1998)

    Article  CAS  Google Scholar 

  33. Doherty, M. & Gratton, A. Differential involvement of ventral tegmental GABAA and GABAB receptors in the regulation of the nucleus accumbens dopamine response to stress. Brain Res. 1150, 62–68 (2007)

    Article  CAS  Google Scholar 

  34. Grace, A. A. & Bunney, B. S. Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur. J. Pharmacol. 59, 211–218 (1979)

    Article  CAS  Google Scholar 

  35. Klitenick, M. A., DeWitte, P. & Kalivas, P. W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12, 2623–2632 (1992)

    Article  CAS  Google Scholar 

  36. Soyka, M., Bottlender, R. & Moller, H. J. Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry 33, 138–141 (2000)

    Article  CAS  Google Scholar 

  37. Rowlett, J. K., Platt, D. M., Lelas, S., Atack, J. R. & Dawson, G. R. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc. Natl Acad. Sci. USA 102, 915–920 (2005)

    Article  ADS  CAS  Google Scholar 

  38. Rudolph, U. & Möhler, H. GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr. Opin. Pharmacol. 6, 18–23 (2005)

    Article  Google Scholar 

  39. Koob, G. F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 42 (suppl. 1). S32–S41 (2009)

    Article  Google Scholar 

  40. Lüscher, C. & Bellone, C. Cocaine-evoked synaptic plasticity: a key to addiction? Nature Neurosci. 11, 737–738 (2008)

    Article  ADS  Google Scholar 

  41. Mameli, M. et al. Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nature Neurosci. 12, 1036–1041 (2009)

    Article  CAS  Google Scholar 

  42. Redish, A. D., Jensen, S. & Johnson, A. A unified framework for addiction: vulnerabilities in the decision process. Behav. Brain Sci. 31, 415–437 (2008)

    Article  Google Scholar 

  43. Labouèbe, G. et al. RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area. Nature Neurosci. 10, 1559–1568 (2007)

    Article  Google Scholar 

  44. Zhao, S. et al. Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. Eur. J. Neurosci. 19, 1133–1140 (2004)

    Article  Google Scholar 

  45. Tamamaki, N. et al. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J. Comp. Neurol. 467, 60–79 (2003)

    Article  CAS  Google Scholar 

  46. Paxinos, G. & Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates (Elsevier, 2004)

  47. Grace, A. A. & Bunney, B. S. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization. Neuroscience 10, 301–315 (1983)

    Article  CAS  Google Scholar 

  48. Ungless, M. A., Magill, P. J. & Bolam, J. P. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303, 2040–2042 (2004)

    Article  ADS  CAS  Google Scholar 

Download references

Acknowledgements

We thank members of the Lüscher laboratory as well as M. Frerking, M. Serafin and H. Möhler for critical reading of the manuscript. Y. Yanagawa provided the GAD67–GFP Δneo mouse line, and we thank K. A. Miczek and H. U. Zeilhofer for help with the GABAA mutant mouse lines. This work is supported by the National Institute on Drug Abuse (NIDA; DA019022; C.L., P. Slesinger), the Swiss National Science Foundation, the Swiss Initiative in Systems Biology (Neurochoice) and the European Commission Coordination Action ENINET (LSHM-CT-2005-19063). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDA or the National Institutes of Health.

Author Contributions K.R.T. carried out all in vitro electrophysiology experiments. M.B., G.L. and C.Y. contributed equally to the in vivo recordings. K.R.T. and C.C. performed the behavioural experiments. J.-M.F. carried out the immunohistochemistry. U.R. generated the mutant mice. C.L. designed the study and wrote the manuscript with the help of all authors.

Author information

Author notes

  1. Matthew Brown, Gwenaël Labouèbe and Cédric Yvon: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Basic Neurosciences, Medical Faculty, University of Geneva, CH-1211 Geneva, Switzerland

    Kelly R. Tan, Matthew Brown, Gwenaël Labouèbe, Cédric Yvon, Cyril Creton & Christian Lüscher

  2. Institute of Pharmacology and Toxicology, University of Zurich, CH-8057 Zurich, Switzerland

    Jean-Marc Fritschy

  3. McLean Hospital and Department of Psychiatry, Laboratory of Genetic Neuropharmacology, Harvard Medical School, Belmont, Massachusetts 02478, USA,

    Uwe Rudolph

  4. Department of Clinical Neurosciences, Clinic of Neurology, Geneva University Hospital, CH-1211 Geneva, Switzerland

    Christian Lüscher

  5. Geneva Neuroscience Center, CH-1211 Geneva, Switzerland

    Christian Lüscher

Authors
  1. Kelly R. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gwenaël Labouèbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cédric Yvon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cyril Creton
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jean-Marc Fritschy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Uwe Rudolph
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Christian Lüscher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Lüscher.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-10 with Legends. (PDF 2647 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, K., Brown, M., Labouèbe, G. et al. Neural bases for addictive properties of benzodiazepines. Nature 463, 769–774 (2010). https://doi.org/10.1038/nature08758

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature08758

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research